综上所述,allo-HSCT后序贯阿伐替尼可作为SM伴RUNX1-RUNX1T1阳性AML有效的治疗手段,主要不良反应为血液学不良反应。. The gene discussed is RUNX1; the disease is acute myeloid leukemia.